1. Home
  2. NC vs AURA Comparison

NC vs AURA Comparison

Compare NC & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NACCO Industries Inc.

NC

NACCO Industries Inc.

HOLD

Current Price

$56.74

Market Cap

401.3M

Sector

Energy

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$5.99

Market Cap

333.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NC
AURA
Founded
1913
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
401.3M
333.4M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
NC
AURA
Price
$56.74
$5.99
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.20
AVG Volume (30 Days)
7.7K
186.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.71%
N/A
EPS Growth
186.01
9.33
EPS
2.87
N/A
Revenue
$104,778,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$20.55
N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.00
$4.73
52 Week High
$58.99
$7.73

Technical Indicators

Market Signals
Indicator
NC
AURA
Relative Strength Index (RSI) 60.71 58.70
Support Level $44.66 $5.81
Resistance Level $58.74 $5.96
Average True Range (ATR) 1.76 0.36
MACD 0.07 0.05
Stochastic Oscillator 66.52 87.80

Price Performance

Historical Comparison
NC
AURA

About NC NACCO Industries Inc.

NACCO Industries Inc is a holding company that operates in the mining and natural resource industries. It has three operating segments that are coal mining, North American mining (NA mining), and minerals management. The majority of its revenue is from the coal mining segment. This segment operates surface coal mines under long-term contracts with power generation companies and an activated carbon producer pursuant to a service-based business model. The NA mining segment provides value-add contract mining and services for producers. Minerals management generates income from royalty-based leases by acquiring and promoting oil, gas, and coal mineral interests. The company is diversifying beyond coal mining due to political and economic pressures associated with carbon emissions.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: